Use of competitive NMDA receptor antagonists in the treatment of

Details Use of competitive NMDA receptor antagonists in the treatment of Use of competitive NMDA receptor antagonists in the treatment of

1992-07-24

1993-03-09

Schenkman, Leonard

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Phosphorus containing other than solely as part of an...

514307, 514326, A61K 3147, A61K 31675

Patent

active

051927519

ABSTRACT:
The present invention provides a method of treating urinary incontinence in a mammal which comprises administering an effective amount of a competitive NMDA antagonist.

REFERENCES:
patent: 4902695 (1990-02-01), Ornstein
patent: 4968678 (1990-11-01), Ornstein
Hansen, Krogsgaard-Larsen, Med. Res. Rev., 10, 55-94 (1990).
Murphy et al., British J. Pharmacol., 95, 932-938 (1988).
Harrison and Simmonds, British J. Pharmacol., 84, 381-391 (1984).
Schoepp et al., J. Neur. Transm., 85, 131-143 (1991).
DeGroat et al., J. Auton. Nerv. Sys., 3, 135-160 (1981).
Shaw et al., Brain Res., 539, 164-168 (1991).
Maggi et al., Eur. J. Pharmacol., 181, 105-109 (1990).
Yoshiyama et al., Neurosci. Lett., 126, 141-144 (1991).
Vera and Nadelhaft, Neurosci. Lett., 134, 135-138 (1991).
Berger et al., J. Urol., 138, 836-838 (1987).
Bradley, Neurolog., 28, 52-58 (1978).
Yoshiyama et al., Neurosci. Abstract, 16, 437.3 (1990).
Matsumoto et al., Neurosci. Lett., 133, 211-214 (1991).

Affiliated with

Also associated with

Rating

Use of competitive NMDA receptor antagonists in the treatment of does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of competitive NMDA receptor antagonists in the treatment of, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of competitive NMDA receptor antagonists in the treatment of will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-211553